Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: go_bucks who wrote (4440)	1/9/1998 3:16:00 PM
From: Tunica Albuginea	Respond to of 23519

Charlie, that's old data, but thanx.Keep looking. ProstglandinE1 (MUSE) has been given to neonates intravenously for almost 10 years.So we have no systemic side effect surprises coming our way like Redux, GG, or that, the forthcoming Viagra, may get (relax BigK, just being objective that's all, gg; it's that old M.D. in me popping up again, GG). Harvard Scientific and Irwin- bicycle-seat-Goldstein is also old. They'll inject " liquid" MUSE into urethra couple of minor,gg. problems. -Vivus holds all patents on transurethral "methods" of delivery. -Liquid MUSE is NOT a good idea) how you going to keep it from "rolling merrilly-merrilly down your bladder" ---> less in your penis and --> more systemically-->hypotension-->syncope-->death-->lawyer, in approximately that sequence,GG. All in my opinion. TA